About
immatics is a clinical-stage biopharmaceutical company active in the discovery and development of t-cell redirecting immunotherapies for the treatment of cancer. our transformative product candidates are - best in class - adoptive cell therapies and bispec
CEOHarpreet Singh
HQTuebingen, Baden Wuerttemberg
Employees381